Adalimumab: all 321 studies that test it

Page 1 of 4. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• An Early Feasibility Study of the BioJet™ Oral Biotherapeutic Delivery System for Administration of Therapeutic Agents in Healthy ParticipantsNot yet recruitingNCT07849153Phase 1
• A Study to Investigate How Well an Intracolonic Formulation of Two Monoclonal Antibodies is Tolerated in Healthy Participants and the Ability for the Antibodies to be Taken up by the Body Via the ColonNot yet recruitingNCT07788807Phase 1
• Adalimumab Dose Adjustment for Pediatric Uveitis Treatment TrialNot yet recruitingNCT07699107Phase 4
• A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07564505Phase 4
• A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque PsoriasisNot yet recruitingNCT07529925Phase 4
• Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained RemissionRecruitingNCT07491913Not applicable
• Preventing Structural Damage in Early Psoriatic ArthritisRecruitingNCT07486843Phase 4
• Apremilast and Adalimumab in Psoriatic Arthritis PatientsNot yet recruitingNCT07398651Not applicable
• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• Biologics in Folliculitis Decalvans : an Adaptative Trial ResearchNot yet recruitingNCT07268534Phase 2
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
• Evaluation of IL 12B Genetic Polymorphism (rs3213094)RecruitingNCT07128472Not applicable
• A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesRecruitingNCT07061574Phase 1/2
• An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)RecruitingNCT06996652Phase 2
• Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing PolychondritisRecruitingNCT06941376Phase 2
• Subconjunctival Humira for Boston KeratoprosthesisNot yet recruitingNCT06926478Phase 1
• Baricitinib in the Treatment of Intestinal Behçet's SyndromeRecruitingNCT06849908Phase 2
• Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing SpondylitisNot yet recruitingNCT06833112Phase 4
• A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's ArteritisRecruitingNCT06498089Phase 4
• Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic UveitisNot yet recruitingNCT06390436Phase 4
• Treatment FOr Corticosteroid Dependent UveitiSNot yet recruitingNCT06258915Phase 3
• Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.RecruitingNCT06180382Phase 4
• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRecruitingNCT06100744Phase 3
• Effects of TNF Blockade on Human BPH/LUTSRecruitingNCT06062875Phase 2
• Study Evaluation of the Efficacy, Safety and Immunogenicity of Adalimumab in Comparison With Humira®RecruitingNCT06005532Phase 3
• Effect of Adalimumab Therapy on Psoriasis PatientNot yet recruitingNCT05889338Not applicable
• "Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"Not yet recruitingNCT05874505Phase 2
• The Clinical Efficacy of Immunomodulators in RA PatientsRecruitingNCT05626348Phase 4
• Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisRecruitingNCT05590455Phase 2
• Immunoclassification of Psoriasis: a Strategy for Precision MedicineRecruitingNCT05503875Not applicable
• Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu ArteritisRecruitingNCT05151848Phase 4
• Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior UveitisRecruitingNCT04798755Phase 3
• De-escalation of Anti-TNF Therapy in Inflammatory Bowel DiseaseEnrolling by invitationNCT04646187Phase 4
• Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingNCT04610476Phase 3
• A Pilot Study in Severe Patients With Takayasu Arteritis.RecruitingNCT04300686Phase 4
• Fluorescence Imaging of IBD and RA Using Adalimumab-800CWRecruitingNCT03938701Phase 2
• Control Crohn Safe TrialRecruitingNCT03917303Phase 4
• Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingNCT03414502Phase 3
• Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious UveitisRecruitingNCT02706704Phase 2
• Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and ImmunogenicityCompletedNCT05637515Phase 3Results posted
• The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"CompletedNCT05299242Phase 2/3Results posted
• A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an InjectionCompletedNCT05203289Phase 1Results posted
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT05073315Phase 3Results posted
• A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to MethotrexateActive, not recruitingNCT04909801Phase 3Results posted
• A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisCompletedNCT04230213Phase 3Results posted
• A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid ArthritisCompletedNCT04171414Phase 3Results posted
• Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change DiseaseCompletedNCT04009668Phase 2Results posted
• Adalimumab vs. Conventional Immunosuppression for Uveitis TrialCompletedNCT03828019Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT03823391Phase 2Results posted
• Adalimumab in JIA-associated Uveitis Stopping TrialCompletedNCT03816397Phase 4Results posted
• Effects of Abatacept on Myocarditis in Rheumatoid ArthritisTerminatedNCT03619876Phase 4Results posted
• Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and TaiwanCompletedNCT03505008Phase 4Results posted
• The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisCompletedNCT03210259Phase 3Results posted
• Repurposing Anti-TNF for Treating Dupuytren's DiseaseCompletedNCT03180957Phase 2Results posted
• Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RACompletedNCT03172325Phase 3Results posted
• MSB11022 in Moderate to Severe Rheumatoid ArthritisCompletedNCT03052322Phase 3Results posted
• Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis SuppurativaCompletedNCT02904902Phase 3Results posted
• A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine TreatmentTerminatedNCT02897115Phase 4Results posted
• Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02850965Phase 3Results posted
• A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)CompletedNCT02814175Phase 4Results posted
• Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-SurgicallyCompletedNCT02808975Phase 4Results posted
• Triple Combination Therapy in High Risk Crohn's Disease (CD)CompletedNCT02764762Phase 4Results posted
• Usability of an AI for M923 in Subjects With Moderate to Severe RACompletedNCT02722044Phase 3Results posted
• MSB11022 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02660580Phase 3Results posted
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisCompletedNCT02640612Phase 3Results posted
• Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled SyringeCompletedNCT02636907Phase 2Results posted
• Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative ColitisCompletedNCT02632175Phase 3Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to MethotrexateActive, not recruitingNCT02629159Phase 3Results posted
• Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or AutoinjectorCompletedNCT02606903Phase 1Results posted
• Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type PsoriasisCompletedNCT02581345Phase 3Results posted
• Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)CompletedNCT02533375Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT02499783Phase 3Results posted
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).CompletedNCT02480153Phase 3Results posted
• IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedNCT02451748Phase 4Results posted
• Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VICompletedNCT02437253Phase 1/2Results posted
• A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis PatientsCompletedNCT02405780Phase 3Results posted
• Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy VolunteersCompletedNCT02395055Phase 1Results posted
• Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to MethotrexateTerminatedNCT02393378Phase 2Results posted
• Treatments Against RA and Effect on FDG-PET/CTCompletedNCT02374021Phase 4Results posted
• A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis PatientsCompletedNCT02260791Phase 3Results posted
• A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) SubjectsCompletedNCT02198651Phase 4Results posted
• Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR StudyCompletedNCT02196701Phase 3Results posted
• Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115CompletedNCT02185014Phase 3Results posted
• Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s DiseaseCompletedNCT02148718Phase 4Results posted
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisCompletedNCT02137226Phase 3Results posted
• Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT02114931Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02065622Phase 3Results posted
• Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT02065570Phase 3Results posted
• Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02065557Phase 3Results posted
• Pharmacokinetics and Safety in Healthy VolunteersCompletedNCT02045979Phase 1Results posted
• A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid ArthritisCompletedNCT02019472Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail PsoriasisCompletedNCT02016482Phase 3Results posted
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and HumiraCompletedNCT02016105Phase 3Results posted
• Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT02015793Phase 2Results posted
• Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque PsoriasisCompletedNCT01970488Phase 3Results posted
• Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid ArthritisCompletedNCT01970475Phase 3Results posted
• A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's DiseaseCompletedNCT01958827Phase 3Results posted
• Vascular Inflammation in Psoriasis - Extension StudyCompletedNCT01866592Phase 4Results posted
• Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial SpondyloarthritisCompletedNCT01808118Phase 3Results posted
• An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateTerminatedNCT01764997Phase 3Results posted

← Adalimumab overview